Cancer and anti-inflammatory drugs

NEW YORK, June 19 (Praxis Press) Drugs such as aspirin, known as non-steroidal anti-inflammatory drugs (NSAIDs), are thought to reduce the risk of colon cancer, but whether these drugs decrease the risk of other types of cancers is unknown. A new study showed that people taking NSAIDs were at reduced risk of esophageal, gastric, colon, and rectal cancers (see paper). But no effect was apparent on the risk of bladder, breast, and lung cancer and the risk of prostatic and pancreatic cancer was inc

June 19, 2000

NEW YORK, June 19 (Praxis Press) Drugs such as aspirin, known as non-steroidal anti-inflammatory drugs (NSAIDs), are thought to reduce the risk of colon cancer, but whether these drugs decrease the risk of other types of cancers is unknown. A new study showed that people taking NSAIDs were at reduced risk of esophageal, gastric, colon, and rectal cancers (see paper). But no effect was apparent on the risk of bladder, breast, and lung cancer and the risk of prostatic and pancreatic cancer was increased. NSAIDs may protect against cancer of the gastrointestinal tract, but their role in reducing the risk of other cancers needs to be studied further.

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Sequencing Reveals Genomic Diversity of the Human Brain
  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech